Skip to main content

Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm

The Original Article was published on 02 December 2015

Unfortunately, after publication of the article [1] it was noticed that Table 2 (Table 1 here) was formatted incorrectly during the production process. The corrected table can be seen below and the original article has been updated to reflect this change.

Table 1 Immunotherapeutic approaches and their application to endometrial cancera

Reference

  1. Longoria TC, Eskander RN. Immunotherapy in endometrial cancer - an evolving therapeutic paradigm. Gynecol Oncol Res Pract. 2015;2:11. doi:10.1186/s40661-015-0020-3.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ramez N. Eskander.

Additional information

The online version of the original article can be found under doi:10.1186/s40661-015-0020-3.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Longoria, T.C., Eskander, R.N. Erratum to: Immunotherapy in endometrial cancer - an evolving therapeutic paradigm. gynaecol oncol res pract 3, 2 (2016). https://doi.org/10.1186/s40661-016-0021-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s40661-016-0021-x